Literature DB >> 11079450

Mutations of LH and FSH receptors.

P Beck-Peccoz1, R Romoli, L Persani.   

Abstract

Gonadotropins control male and female gonadal function by acting through specific receptors. The recent description of several mutations in LH and FSH receptors has significantly improved our understanding of the pathophysiology of several sexual disorder. Both gain- and loss-of-function germline mutations leading to constitutive receptor activation or to hormone resistance have been described. The clinical impact of these mutant receptors can be markedly different, depending upon the sex of the affected patient and the degree of functional alteration. Numerous mutations were described in LH receptor gene. Constitutive activation of this receptor leads to male-limited precocious pseudopuberty, whereas hypergonadotropic hypogonadism is the clinical phenotype of LH resistance. On the other hand, few mutations of FSH receptor were described so far. Inactivating mutations of FSH receptor are involved in some cases of hypergonadotropic hypogonadism with a more severe impairment of fertility in female patients. Only one gain-of-function mutation of FSH receptor was reported to maintain fertility in one hypophysectomized man. This review is focused on the known genetic alterations of gonadotropic receptors in humans and their impact on male sexual differentiation and fertility.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11079450     DOI: 10.1007/BF03343777

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  43 in total

Review 1.  Mutations of follicle stimulating hormone-beta and its receptor in human and mouse: genotype/phenotype.

Authors:  L C Layman; P G McDonough
Journal:  Mol Cell Endocrinol       Date:  2000-03-30       Impact factor: 4.102

2.  Brief report: testicular and ovarian resistance to luteinizing hormone caused by inactivating mutations of the luteinizing hormone-receptor gene.

Authors:  A C Latronico; J Anasti; I J Arnhold; R Rapaport; B B Mendonca; W Bloise; M Castro; C Tsigos; G P Chrousos
Journal:  N Engl J Med       Date:  1996-02-22       Impact factor: 91.245

3.  New natural inactivating mutations of the follicle-stimulating hormone receptor: correlations between receptor function and phenotype.

Authors:  P Touraine; I Beau; A Gougeon; G Meduri; A Desroches; C Pichard; M Detoeuf; B Paniel; M Prieur; J R Zorn; E Milgrom; F Kuttenn; M Misrahi
Journal:  Mol Endocrinol       Date:  1999-11

4.  The Finnish follicle-stimulating hormone receptor gene mutation is rare in North American women with 46,XX ovarian failure.

Authors:  L C Layman; S Amde; D P Cohen; M Jin; J Xie
Journal:  Fertil Steril       Date:  1998-02       Impact factor: 7.329

5.  Male hypogonadism caused by homozygous deletion of exon 10 of the luteinizing hormone (LH) receptor: differential action of human chorionic gonadotropin and LH.

Authors:  J Gromoll; U Eiholzer; E Nieschlag; M Simoni
Journal:  J Clin Endocrinol Metab       Date:  2000-06       Impact factor: 5.958

6.  No evidence of a role for mutations or polymorphisms of the follicle-stimulating hormone receptor in ovarian granulosa cell tumors.

Authors:  P J Fuller; K Verity; Y Shen; P Mamers; T Jobling; H G Burger
Journal:  J Clin Endocrinol Metab       Date:  1998-01       Impact factor: 5.958

7.  Men homozygous for an inactivating mutation of the follicle-stimulating hormone (FSH) receptor gene present variable suppression of spermatogenesis and fertility.

Authors:  J S Tapanainen; K Aittomäki; J Min; T Vaskivuo; I T Huhtaniemi
Journal:  Nat Genet       Date:  1997-02       Impact factor: 38.330

Review 8.  Luteinizing hormone receptor mutations and sex differentiation.

Authors:  A P Themmen; H G Brunner
Journal:  Eur J Endocrinol       Date:  1996-05       Impact factor: 6.664

9.  A homozygous mutation in the luteinizing hormone receptor causes partial Leydig cell hypoplasia: correlation between receptor activity and phenotype.

Authors:  J W Martens; M Verhoef-Post; N Abelin; M Ezabella; S P Toledo; H G Brunner; A P Themmen
Journal:  Mol Endocrinol       Date:  1998-06

10.  The unique exon 10 of the human luteinizing hormone receptor is necessary for expression of the receptor protein at the plasma membrane in the human luteinizing hormone receptor, but deleterious when inserted into the human follicle-stimulating hormone receptor.

Authors:  F P Zhang; J Kero; I Huhtaniemi
Journal:  Mol Cell Endocrinol       Date:  1998-07-25       Impact factor: 4.102

View more
  3 in total

1.  Genetic analysis of the follicle stimulating hormone receptor gene in women with polycystic ovary syndrome.

Authors:  F Orio; E Ferrarini; T Cascella; A Dimida; S Palomba; E Gianetti; A Colao; P Agretti; P Vitti; G Lombardi; A Pinchera; M Tonacchera
Journal:  J Endocrinol Invest       Date:  2006-12       Impact factor: 4.256

2.  Precocious Puberty in a Boy With Bilateral Leydig Cell Tumors due to a Somatic Gain-of-Function LHCGR Variant.

Authors:  Chelsi Flippo; Vipula Kolli; Melissa Andrew; Seth Berger; Tricia Bhatti; Alison M Boyce; Daniel Casella; Michael T Collins; Emmanuèle Délot; Joseph Devaney; Stephen M Hewitt; Thomas Kolon; Ashwini Mallappa; Perrin C White; Deborah P Merke; Andrew Dauber
Journal:  J Endocr Soc       Date:  2022-08-12

3.  Mutational analysis of the human FATE gene in 144 infertile men.

Authors:  Christian Olesen; Joachim Silber; Hans Eiberg; Erik Ernst; Karsten Petersen; Svend Lindenberg; Niels Tommerup
Journal:  Hum Genet       Date:  2003-06-14       Impact factor: 4.132

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.